D a t a s o u r c e s
Studies were identified by searching the Cochrane Controlled Trials Register, MEDLINE, EMBASE/Excerpta Medica, and CINAHL; schools of podiatry and manufacturers of cryotherapy, radiowave, and electrosurgical equipment were contacted; and reference lists of relevant studies were reviewed.
S t u d y s e l e c t i o n
Studies were selected if they were randomized or quasi-randomized trials that compared 1 form of surgery with another or with other treatments that aimed to permanently remove all or part of an ingrown toenail and had ≥ 6 months of follow-up.
D a t a e x t r a c t i o n
Data were extracted on study quality (allocation concealment, intention-to-treat analysis, baseline comparability, and followup). Outcomes considered were regrowth, relief of symptoms, healing time, infection, postoperative pain, and patient satisfaction.
M a i n r e s u l t s 9 studies were included. 1 study that compared nail avulsion and phenol with nail avulsion alone showed that the addition of phenol reduced symptomatic recurrence {P < 0.001}* but increased the rate of postoperative infection {P = 0.002}*; fewer patients receiving phenolization, however, were dissatisfied {P < 0.001}* (Table) . Avulsion with phenol reduced symptomatic recurrence (5 trials) {P = 0.008}* more than did surgical excision, and treatments did not differ for postoperative infection (2 trials) {P = 0.28}* (Table) . Insufficient data were available to quantify other outcomes.
C o n c l u s i o n s
In patients with ingrown toenails, nail avulsion with phenol is more effective in preventing recurrence than avulsion alone or surgical excision. 1 study shows avulsion with phenol increases postoperative infection. 
C o m m e n t a r y
The meta-analysis by Rounding and Hulm evaluates surgical methods for the treatment of ingrown toenails. The authors conclude that phenol with avulsion was superior to surgical excision for prevention of symptomatic recurrence but at the cost of increased rates of postoperative infection. Surgical and carbolic acid (phenol) treatment of ingrown toenails has been used concurrently since 1901 or before (1) . Both have been reported successful at permanently eradicating symptomatic ingrown toenails. Basic surgical principles deem it reasonable to hypothesize that surgical excision of the matrix by any of a number of techniques will consistently result in less postoperative inflammation than phenolization, which, because of its caustic nature, has the potential to cause soft-tissue or bony infection (2) . At least 1 author, however, maintains that the overall potential for complications with phenol or surgical treatment is similar (3).
Rounding and Hulm have done a good job of synthesizing their conclusions in this review of a wide range of studies with different design criteria, inclusion parameters, and secondary outcome measures (i.e., differences in healing times and degree of pain).
Because of the caustic nature of phenol, a priori use in medically immunocompromised or ischemic patients should be contraindicated. However, Felton and Weaver (4) state that phenol can be used in patients with diabetes mellitus.
Rounding and Hulm's conclusions appear reasonable. The following 3 study parameters, however, should also be considered: the experience and professions of a representative sample of surgeons, the degree of infection in the ingrown toenail before treatment, and the age and medical history of the study patients.
If this review were expanded to include such treatments as negative galvanism, trephine, osteotrypsy, laser ablation (3) 
